N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143972 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143973 |
| CAS No | NA |
| Mol.F. | C7H14N2O2 |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143974 |
| CAS No | NA |
| Mol.F. | C8H10N2O |
| Mol.Wt. | 150.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143975 |
| CAS No | NA |
| Mol.F. | C5H8N2O2 |
| Mol.Wt. | 128.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143976 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143977 |
| CAS No | 1822857-11-3 |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143978 |
| CAS No | NA |
| Mol.F. | C4H10ClN3O |
| Mol.Wt. | 151.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143979 |
| CAS No | 83008-57-5 |
| Mol.F. | C3H8N4O |
| Mol.Wt. | 116.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143980 |
| CAS No | 1354380-71-4 |
| Mol.F. | C3H7N5O2 |
| Mol.Wt. | 145.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143981 |
| CAS No | NA |
| Mol.F. | C6H14N4O |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143982 |
| CAS No | NA |
| Mol.F. | C13H17N5O |
| Mol.Wt. | 259.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143983 |
| CAS No | 52764-44-0 |
| Mol.F. | C5H12N4O |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143984 |
| CAS No | NA |
| Mol.F. | C8H14N6O2 |
| Mol.Wt. | 226.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143985 |
| CAS No | NA |
| Mol.F. | CH3N3O2 |
| Mol.Wt. | 89.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143986 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143987 |
| CAS No | NA |
| Mol.F. | C5H6N2O4 |
| Mol.Wt. | 158.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |